Research
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people
BMJ 2006; doi: https://doi.org/10.1136/bmj.38993.731725.BE (Published 10 November 2006) Cite this as: BMJ 2006;:bmj;bmj.38993.731725.BEv1
Related articles
- Paper Published: 12 September 1998; BMJ 317 doi:10.1136/bmj.317.7160.720
- Education And Debate Published: 11 March 2004; BMJ 328 doi:10.1136/bmj.328.7440.634
- Education And Debate Published: 22 July 2004; BMJ 329 doi:10.1136/bmj.329.7459.224
- This Week In The BMJ Published: 30 November 2006; BMJ 333 doi:10.1136/bmj.333.7579.0-a
- Research Methods & Reporting Published: 11 April 2011; BMJ 342 doi:10.1136/bmj.d1766
See more
- Introductory AddressProv Med Surg J October 03, 1840, s1-1 (1) 1-4; DOI: https://doi.org/10.1136/bmj.s1-1.1.1
- Report of the Meeting of the Eastern Branch of the Provincial Association at Bury St. Edmond'sProv Med Surg J October 03, 1840, s1-1 (1) 10-13; DOI: https://doi.org/10.1136/bmj.s1-1.1.10
- Mr. Warburton's Bill for the Regulation of the Medical ProfessionProv Med Surg J October 03, 1840, s1-1 (1) 13-15; DOI: https://doi.org/10.1136/bmj.s1-1.1.13
- An Atlas of Plates, illustrative of the Principles and Practice of Obstetric Medicine and Surgery, with descriptive LetterpressProv Med Surg J October 03, 1840, s1-1 (1) 4; DOI: https://doi.org/10.1136/bmj.s1-1.1.4
- A Practical Treatise on the Diseases peculiar to Women, illustrated by Cases, &cProv Med Surg J October 03, 1840, s1-1 (1) 4-5; DOI: https://doi.org/10.1136/bmj.s1-1.1.4-a
Cited by...
- Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model
- Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK
- Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs
- The effect of statins on average survival in randomised trials, an analysis of end point postponement
- A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation
- Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes
- Targets for Body Fat, Blood Pressure, Lipids, and Glucose-Lowering Interventions in Healthy Older People
- Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
- The Cost-Effectiveness of C-Reactive Protein Testing and Rosuvastatin Treatment for Patients With Normal Cholesterol Levels
- American Diabetes Association Indications for Statins in Diabetes: Is there evidence?
- Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels
- The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial
- Simvastatin was cost effective across a broad range of risk and age groups
- Statins Possibly More Cost-Effective Than Initially Thought
- How Broadly Do Statin Benefits Extend?